Genomic features underlying spatial heterogeneity in homologous recombination deficiency scores in ovarian high grade serous cancer

被引：0
|
作者：
Lorentzen, Marc [1 ]
Christie, Elizabeth [2 ]
Liu, Maiqi [1 ]
Curry, Edward [1 ]
Pandey, Ahwan [2 ]
Nixon, Katherine [1 ]
Ploski, Jennifer [1 ]
Dickie, Catriona [1 ]
Kondyliou, Lydia [1 ]
Clark, James [1 ]
Mcneish, Iain [1 ]
Krell, Jonathan [1 ]
Fotopoulou, Christina [1 ]
Cunnea, Paula [1 ]
机构：
[1] Imperial Coll London, London, England
[2] Peter MacCallum Canc Ctr, Melbourne, Australia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.998
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
936
引用
收藏
页码：A509 / A509
页数：1
相关论文
共 50 条
  • [21] AI - optimized genomic homologous recombination deficiency test (HRDScar) to predict platinum and PARP inhibitor responses in high-grade serous ovarian cancer.
    Perez-Villatoro, Fernando
    Oikkonen, Jaana
    Tumiati, Manuela
    Casado, Julia
    Hietanen, Sakari
    Hynninen, Johanna
    Garcia, Elizabeth P.
    Konstantinopoulos, Panagiotis
    Hautaniemi, Sampsa
    Kauppi, Liisa
    Farkkila, Anniina
    CANCER RESEARCH, 2021, 81 (13)
  • [22] A Benchmark of In-House Homologous Recombination Repair Deficiency Testing Solutions for High-Grade Serous Ovarian Cancer Diagnosis
    Guarischi-Sousa, Rodrigo
    Kroll, Jose Eduardo
    Bonaldi, Adriano
    Pierry, Paulo Marques
    Villela, Darine
    Souza, Camila Alves
    Silva, Juliana Santos
    Buerger, Matheus Carvalho
    Oliveira, Felipe Azevedo
    de Paula, Marcelo Gomes
    Meliso, Fabiana Marcelino
    de Almeida, Luiz Gustavo
    Monfredini, Priscilla Morais
    de Oliveira, Ana Gabriela
    Milanezi, Fernanda
    Scapulatempo-Neto, Cristovam
    Yamamoto, Guilherme Lopes
    DIAGNOSTICS, 2023, 13 (21)
  • [23] LOSS OF FRAGILE HISTIDINE TRIAD PROTEIN EXPRESSION IS ASSOCIATED WITH HOMOLOGOUS RECOMBINATION DEFICIENCY IN HIGH-GRADE SEROUS OVARIAN CANCER
    Sarvilinna, N.
    Virtanen, A.
    Tumiati, M.
    Kauppi, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A641 - A642
  • [24] Dynamically Accumulating Homologous Recombination Deficiency Score Served as an Important Prognosis Factor in High-Grade Serous Ovarian Cancer
    Su, Rongjia
    Liu, Yuan
    Wu, Xiaomei
    Xiang, Jiangdong
    Xi, Xiaowei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [25] Homologous recombination deficiency (HRD) score and niraparib efficacy in high grade ovarian cancer
    Haluska, P.
    Timms, K. M.
    AlHilli, M.
    Wang, Y.
    Hartman, A. M.
    Jones, J.
    Gutin, A.
    Sangale, Z.
    Neff, C.
    Lynchbury, J.
    Rudolph-Owen, L.
    Becker, M. A.
    Agarwal, S.
    Wilcoxen, K. M.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 73
  • [26] Copy number features as a novel biomarker of homologous recombination (HR) status in high-grade serous ovarian cancer (HGSOC).
    Romero Lozano, Paula
    Vila-Casadesus, Maria
    Matito, Judit
    Garcia-Duran, Carmen
    Grazia Lo Giacco, Deborah
    Gomez-Rey, Marina
    Francisco Grau, Juan
    Farinas-Madrid, Lorena
    Hernandez-Illan, Eva
    Martin, Agatha
    Garcia, Cecilia
    Castillo, Ester
    Miquel Aymar, Josep Maria
    Tabernero, Josep
    Oaknin, Ana
    Vivancos, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [27] Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
    Matsumura, Noriomi
    Takaya, Hisamitsu
    Takamatsu, Shiro
    Nakai, Hidekatsu
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 63 - 63
  • [28] Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
    Schwarz, Roland F.
    Ng, Charlotte K. Y.
    Cooke, Susanna L.
    Newman, Scott
    Temple, Jillian
    Piskorz, Anna M.
    Gale, Davina
    Sayal, Karen
    Murtaza, Muhammed
    Baldwin, Peter J.
    Rosenfeld, Nitzan
    Earl, Helena M.
    Sala, Evis
    Jimenez-Linan, Mercedes
    Parkinson, Christine A.
    Markowetz, Florian
    Brenton, James D.
    PLOS MEDICINE, 2015, 12 (02)
  • [29] Genomic signatures as predictive biomarkers of homologous recombination deficiency in ovarian cancer
    Vanderstichele, Adriaan
    Busschaert, Pieter
    Olbrecht, Siel
    Lambrechts, Diether
    Vergote, Ignace
    EUROPEAN JOURNAL OF CANCER, 2017, 86 : 5 - 14
  • [30] Frequency of homologous recombination deficiency in high-grade serous ovarian cancer in Japan; JGOG3025-TR2 study
    Matsumura, Noriomi
    Takamatsu, Shiro
    Yoshihara, Kosuke
    Baba, Tsukasa
    Shimada, Muneaki
    Yoshida, Hiroshi
    Okamoto, Aikou
    Kajiyama, Hiroaki
    Oda, Katsutoshi
    Enomoto, Takayuki
    CANCER SCIENCE, 2022, 113 : 827 - 827
12345